Last reviewed · How we verify

NCT04405531

Effects of TOT on Performance, Independence and Fatigue in Children With Cancer

Completed NA Last updated 28 May 2020
What this trial tests

NA trial testing task-oriented training (TOT) in Childhood Cancer in 213 participants. Completed in 13 January 2020.

Timeline
1 January 2019
Primary endpoint
3 January 2020
13 January 2020

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment213
Start date1 January 2019
Primary completion3 January 2020
Estimated completion13 January 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 6 to 14, any sex, with Childhood Cancer or Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to explore the effects of Task-Oriented Training (TOT) on occupational performance, activities of daily living and fatigue of children in pediatric oncology clinic. Hypothesis: There is no effect of TOT on occupational performance and satisfaction in children with childhood cancer. There is no effect of TOT on functional independence in daily living activities in children with childhood cancer. There is no effect of TOT on fatigue levels in children with childhood cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Childhood Cancer

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04405531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing